Capricor Therapeutics Inc <CAPR.O>: Piper Sandler cuts to neutral from overweight; cuts target price to $2 from $58
CAPR•Related News
BP starts up Atlantis facility expansion project in Gulf of Mexico
BP•
Haleon Reports in-line quarterly sales growth as oral health, North America drive demand
HLN•
Stellantis Q2 FY26 net profit returns to €0.3 billion; net revenues rise 13% to €43.5 billion vs Q2 FY25
STLA•
Lloyds hikes interim dividend 30% to 1.58p per share
LYG•
Shell Q2 FY26 adjusted earnings rise to $9.84 billion; IFRS net income climbs to $10.8 billion
SHEL•